Will Cannabis Genetics Be Restricted?
A redefinition of hemp under federal law, scheduled to take effect Nov. 12, signals the loss of Farm Bill safeguards for many hemp-derived THC products across the country: mild beverages as well as THCA flower and delta-8 THC gummies, vapes and additional products available at gas stations and smoke shops.
But the hemp prohibition also generates a significant complication for the legitimate cannabis sector. Seeds from cannabis varieties that produce flower with more than 0.3% THC are no longer legal to ship out of state.
Although seed purchases will likely continue in legal states, the modifications threaten to shutter some seed banks and genetics companies, observers note, while causing supply-chain issues for cannabis cultivators and retailers.
"If this wording goes through, we will require pop-up shops to offer seeds in each state where it's legal," Campanella said. "Which is why we're also providing clones and tissue culture, because that's not included in the bill."
When are cannabis seeds and clones prohibited to ship between state lines?
The updated regulations classify seeds based on the THC capacity of the mother plant. Genetic substances such as seeds and clones are made illegal if the final product exceeds the threshold.
For the moment, seeds are still shipping under the 2018 Farm Bill's current quo. But the time is ticking for enterprises like Brothers Grimm and for cannabis cultivators who worry about supply chain disruptions if out-of-state availability to genetics is prohibited.
Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics marketplace, said Ryan Power, https://nativesusa.com/ (nativesusa.com) cofounder of Sebastopol, California-based breeder Atlas Seed.
Without federal intervention in the way of an exception for seeds or an overall moratorium, numerous seed suppliers will just be shuttered by November, he added.
"We are operating legally now, but if that changes, it will disrupt the legitimate licensed industry in every state," said Power, whose clientele includes seed banks as well as licensed business cultivators.
"Consumers are going to forfeit choice, and it will be a significant shutdown for many people."
What are cannabis seed suppliers doing to stay legal after the government hemp ban?
Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics business, because of state Senate Bill 56, which strengthened cannabis oversight in that state while also restricting hemp-derived THC items to licensed cannabis retailers.
Previously a seed supplier, Silberhaze is currently focused on the marketing, preservation and IP protection of elite plant genetics.
That's because seed businesses hoping to stay compliant in this new environment must have airtight documentation, he said.
"You have to demonstrate where this stuff comes from, so it's very important to have documentation, even to the point where you have cultivator names," Silber said.
"Smaller businesses will have to operate with better records and a stronger chain of custody," he added. "We want that documentation too, because we don't want to be dealing with shady sources."
To avoid seizures and additional legal fallout, seed entrepreneurs must "get their affairs in order" before the new regulations take place, Silber said.
"Audit all your materials immediately, and categorize what you can," Silber said. "Take stock, document your heritage, preserve cultivator records, and arrange any cannabinoid or terpene information you currently have. If regulations shift, you'll be in a much better position to understand what may be affected and make educated decisions."
Does government marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration registration may be necessary for companies engaged in research.
But for the time being, seed houses can't enroll with the DEA like state-licensed medical cannabis businesses can. Such a pathway is not available to seed banks, nurseries or genetics businesses, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis practice group in Cleveland.
"Seed-related activity may be happening inside broader state-licensed therapeutic marijuana operations, as some states permit dispensaries or registered therapeutic operators to offer seeds, clones or home-cultivation materials," he said.
"But that is distinct from the DEA creating a freestanding seed supplier registration category."
Some genetics companies are already changing operational practices to comply with the new law. According to Ickes, they must address questions including:
- Which of our varieties produce plants over 0.3% total THC?
- Which seeds survive as hemp after Nov. 12, 2026, and which don't?
- What does our catalog look like once we sort it against the viable-seed exclusion?
Ickes also recognizes confusion from clients who believed federal rescheduling of therapeutic marijuana would clarify their story with financial institutions. However, the recent regulatory language has moved those conversations beyond the basics of classification, he said.
"Financial institutions ask whether this specific revenue source is lawful, whether it ties to state-licensed operations, or whether there's cross-state risk," said Ickes.
"After November, a seed bank selling drug-type genetics can't answer the initial question with the hemp classification. It has to point to a lawful state cannabis pathway instead. Seed banks dealing in genuine industrial-hemp seed maintain the simpler story."
What's the future of cannabis genetics?
Campanella is a member of a emerging coalition of other breeders, farmers and researchers that's arguing seeds are better defined as agricultural inputs than controlled substances. To that effect, seeds should be overseen by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement work elsewhere.
"How do you regulate something based on what it might become one day?" said Campanella. "Our choice is to have that language removed, or have seeds regulated by the USDA as a hemp product."
But in the meantime, Campanella is restructuring Brothers Grimm to function outside the reach of changing federal oversight. The company plans to maintain its Colorado seed facility while positioning its Oklahoma tissue cultivation facility as a safeguard against government prohibition of cannabis seeds.
As she explained: "If things evolve in a way where we can't concentrate on interstate shipping, we'll have additional resources to meet people's needs without putting ourselves in trouble."
